Crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[ 1-(pyridin-2-ylmethyl)piperidin-4-yl)-1H-i ndol-3-yl]-1H-pyrrole mono-hydrochloride

Details for Australian Patent Application No. 2003280958 (hide)

International Classifications

Event Publications

4 March 2004 Complete Application Filed

Priority application(s): 60/395,976 12.07.02 US

18 March 2004 Application Open to Public Inspection

Published as AU-B-2003280958

18 December 2008 Application Accepted

Published as AU-B-2003280958

19 February 2009 Corrigenda

Applications Accepted - Name Index Under the name Eli Lilly and Company, Application No. 2003280958, under INID(54), correct the title to Crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4yl]-1H-indol-3-yl]-1H-pyrrole mono-hydrochloride

23 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.